Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

NCT01488487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Adult Hepatocellular Carcinoma

Interventions

DRUG: Everolimus
DRUG: Pasireotide

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]